Advanced Medical Imaging (AMI) recently announced the addition of the MammoReader™, a computer-aided detection system for breast cancer, to its women’s care services. Recently, the FDA gave its approval to the machine which searches for all primary signs of breast cancer and can help detect breast cancer earlier.

An unblended retrospective study of 327 cancer cases showed that 23 percent (95 percent CI, 18-28 percent) of woman diagnosed with breast cancer, who had prior screening mammograms, could have had their cancers discovered earlier, by an average of 14 months, with the use of the MammoReader.

“This is an important breakthrough in the fight against breast cancer,” noted Tim Gleason, M.D. Radiologist at AMI. “Detecting breast cancer while still localized increases the 5-year breast cancer survival rate to approximately 96.8 percent or better. That is why AMI has made this investment in our community’s breast care health.”

Gleason added that the device does not replace a woman’s regular screening mammogram or require any additional testing, but does makes a regular screening mammogram more effective by analyzing a patient’s conventional mammogram by searching for all primary signs of breast cancer.

“I like to think of the MammoReader as offering a ‘second set of eyes’ in the screening mammogram process. In most cases, this additional analysis is fully reimbursable, avoiding any additional cost to the patient,” noted Gleason.